GlobeNewswire

ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
04/11/2026
3Q 2026 Total Revenue of $141.1 Million, Increasing 5% Year-over-Year 3Q 2026 ASCENIV Revenue of $124.7 Million, Increasing 31% Year-over-Year 3Q 2026 GAAP Net Income of $49.9 Million, Increasing 37% Year-over-Year 3Q [...]
BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
04/11/2026
MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026
04/11/2026
Company highlights to include strategy for entering CD228V Co-development and Licensing Agreement and Proposed SkinJect® Business Combination and Concurrent Financing LOI PHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- [...]
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
04/11/2026
Phase 3 ReDiscover-2 trial in 2L breast cancer expected to complete enrollment in mid-2027 Updated data from ongoing Phase 1/2 ReInspire trial of zovegalisib in vascular anomalies to be featured in oral presentation at [...]
Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
04/11/2026
BALA CYNWYD, Pa., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced [...]
Clover Health Reports Third Quarter 2026 Results
04/11/2026
Business Highlights: Strong third quarter performance brings year-to-date GAAP Net Income to $62 million alongside 49% year-over-year Medicare Advantage membership growth Improved Full Year 2026 guidance across all [...]
Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update
04/11/2026
VAX-31 Adult Indication: Announced Positive Topline Data from OPUS-1 Pivotal Phase 3 Trial; VAX-31 Met All Prespecified Primary Endpoints, Was Well Tolerated and Demonstrated a Safety Profile Similar to PCV20 and PCV21 [...]
PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
04/11/2026
SAN JOSE, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results
04/11/2026
SEATTLE, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
04/11/2026
– Commercialization plans for lorundrostat are on track ahead of PDUFA target date of December 22, 2026 – – New analyses from the pivotal Launch-HTN trial showed 46% of participants with uncontrolled or resistant [...]
Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance
04/11/2026
MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
PacBio Announces Third Quarter 2026 Financial Results
04/11/2026
MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2026. Recent Business Highlights Delivered total revenue of $40.6 million [...]
New Research Suggests hERG IC₁₀ May Improve Prediction of Drug-Induced QT Prolongation
04/11/2026
NEW ORLEANS, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Dr. William J. Crumb Jr., Ph.D., President and CEO of Nova Research Laboratories, LLC, has collaborated with Dr. Andrew G. Edwards, Ph.D., Chief Research Scientist of [...]
Guidepoint Qsight Launches Consumer Sentiment Tool to Understand Motivations, Behavior & Trends in Aesthetics
04/11/2026
New York, NY, Nov. 04, 2026 (GLOBE NEWSWIRE) -- New Qsight Platform Provides Powerful Insights into Both Current and Prospective Patients in the Medical Aesthetics Market Captures the total addressable market, both [...]
Hennick Humber Hospital Opened Its Doors to 150 Students to Explore the Future of Healthcare
04/11/2026
Annual Take Our Kids to Work Day experience gave young people a firsthand look at the people, technology and career possibilities shaping modern healthcare TORONTO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- What did the future [...]
Pacific Health Care Organization, Inc. Reports its Third Quarter 2026 Financial Results
04/11/2026
Irvine, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q [...]
Neion Bio Taps John Maga as Head of Biologics and CMC to Expand Capabilities In Innovative Development
04/11/2026
Veteran biopharmaceutical executive brings deep experience across complex therapeutic modalities as Neion expands the Raptor platform for innovative and difficult-to-express proteins NEW YORK, Nov. 04, 2026 (GLOBE [...]
Standard Dental Labs Acquires M&D Dental Arts; Announces December 1 Launch Target for Bridge AI Software
04/11/2026
Acquisition expected to double Orlando laboratory output; internally developed platform connects digital dentistry workflows and lays groundwork for AI-assisted restoration design ORLANDO, Fla., Nov. 04, 2026 (GLOBE [...]
Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
04/11/2026
Lyon (France), November 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its nine-month 2026 financial results on Tuesday, November 24, 2026. The [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum